SEATTLE, Aug. 26, 2013 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), today announced that it will be participating in two upcoming investor conferences.
NanoString Technologies management is scheduled to participate in the 2013 Morgan Stanley Global Healthcare Conference in New York on Monday, September 9, 2013 at 11:45 am ET.
NanoString Technologies management is also scheduled to present at the 2013 Baird Healthcare Conference in New York on Wednesday, September 11, 2013 at 10:15 am ET.
Interested parties can access the live audio webcasts for both conferences at www.nanostring.com. Archived presentations will be available on the website for 30 days following each presentation.
About NanoString Technologies, Inc.
NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company's nCounter® Analysis System, which has been employed in basic and translational research since it was first introduced in 2008 and cited in more than 240 peer-reviewed publications, has also now been applied to diagnostic use in the European Union. The system offers a cost-effective way to easily profile the expression of hundreds of genes, miRNAs, or copy number variations, simultaneously with high sensitivity and precision. The company's technology enables a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The nCounter-based Prosigna™ Breast Cancer Prognostic Gene Signature Assay is the first in vitro diagnostic kit to be marketed by the company.
The nCounter Analysis System is available for "Research Use Only" in North America. The Prosigna Assay has received a CE mark and is available for use by healthcare professionals in the European Union and other countries that recognize the CE Mark and in which Prosigna is registered; it is pending 510(k) clearance with the Food and Drug Administration and is not available for sale in the United States.
The NanoString Technologies logo, NanoString, NanoString Technologies, nCounter and Prosigna are registered trademarks or trademarks of NanoString Technologies, Inc. in various jurisdictions.